Evolutionary Action Score Identifies a Subset of TP53 Mutated Myelodysplastic Syndrome with Favorable Prognosis

Authors

Rashmi Kanagal-Shamanna, University of Texas MD Anderson Cancer Center
Guillermo Bravo, University of Texas MD Anderson Cancer Center
Panagiotis Katsonis, Baylor College of Medicine
Koji Sasaki, University of Texas MD Anderson Cancer Center
Caleb Class, University of Texas MD Anderson Cancer Center
Christopher Benton, University of Texas MD Anderson Cancer Center
Elias Jabbour, University of Texas MD Anderson Cancer Center
Kelly Chien, University of Texas MD Anderson Cancer Center
Rajyalakshmi Luthra, University of Texas MD Anderson Cancer Center
Carlos Bueso-Ramos, University of Texas MD Anderson Cancer Center
Tapan Kadia, University of Texas MD Anderson Cancer Center
Michael Andreeff, University of Texas MD Anderson Cancer Center
Nicholas Short, University of Texas MD Anderson Cancer Center
Naval Daver, University of Texas MD Anderson Cancer Center
Mark Routbort, University of Texas MD Anderson Cancer Center
Joseph Khoury, University of Texas MD Anderson Cancer Center
Keyur Patel, University of Texas MD Anderson Cancer Center
Irene Ganan-Gomez, University of Texas MD Anderson Cancer Center
Yue Wei, University of Texas MD Anderson Cancer Center
Gautam Borthakur, University of Texas MD Anderson Cancer Center
Farhad Ravandi, University of Texas MD Anderson Cancer Center
Kim-Anh Do, University of Texas MD Anderson Cancer Center
Kelly Soltysiak, University of Texas MD Anderson Cancer Center
Olivier Lichtarge, Baylor College of Medicine
L. Medeiros, University of Texas MD Anderson Cancer Center
Hagop Kantarjian, University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero, University of Texas MD Anderson Cancer Center

Document Type

Article

Publication Date

November 2020

Publication Title

Blood

First Page

4

Last Page

5

DOI

10.1182/BLOOD-2020-141411

Share

COinS